Definitive Proxy for MTS Medication Technologies

I’ve been slowly building a position in a small risk arb play: MTS Medication Technologies (Ticker: MTSI), which is being acquired for $5.75 in cash. I’m only half way done building a position. It’s very hard to build a position in this company because the stock is so thinly traded. You have to be patient or else you’re going to end up over paying. The company posted its definitive proxy statement today (click: here) and the shareholder vote will take place on December 18th. It’s looking like a December close. Now, I just hope I can get a few more shares at a decent price!